RNA, U6 small nuclear 452, pseudogene (RNU6-452P)

RNA, U6 small nuclear 452, pseudogene (RNU6-452P) is a noncoding pseudogene derived from the U6 small nuclear RNA gene, present in the human genome, generally not classified as a therapeutic target nor directly associated with disease or drug interactions[4][5]. RNU6-452P refers to a processed pseudogene, derived from the U6 small nuclear RNA (snRNA) family, which is highly conserved and essential for spliceosome-mediated pre-mRNA splicing in eukaryotes[1][3]. The “452” indicates its genomic distinction among the many U6 gene copies and pseudogenes present in the human genome[4][5]. Unlike functional U6 snRNA, which forms part of the spliceosome, RNU6-452P does not code for an active RNA molecule nor contribute to normal RNA splicing. Pseudogenes like RNU6-452P may sometimes be transcribed, but there is no evidence this particular locus has biological function or relevance to human disease, clinical applications, or pharmacology. Pseudogenes in general can exert regulatory effects, sometimes acting as antisense RNAs or competing endogenous RNAs (ceRNAs), potentially influencing gene expression[6]. However, most U6-derived pseudogenes, including RNU6-452P, have not been implicated in clinically relevant regulatory mechanisms or disease processes, and their biological roles—if any—are largely uncharacterized[4][5][6]. Current structured information for RNU6-452P should reflect its status as a noncoding pseudogene with no established role as a therapeutic target, drug interactor, biomarker, or disease gene.

Other names

RNU6-452PRNA, U6 small nuclear 452, pseudogene